Abstract:With the growth in antiepileptic drug treatment, the question arises as to what extent we are merely treating the symptom (i.e. the seizures) rather than the underlying disease process (i.e. epileptogenesis). Epilepto genicity can be considered as the process whereby structural and functional changes occur following an insult that in some cases result in epilepsy. Epilepto genicity also describes some of the changes and processes that contribute to the progression observed in some epilepsies. These processes have been modelled in animals mostly by the kindling model of epilepsy, in which repetition of subconvulsive stimuli results in a progressive epileptic state and eventually leads to spontaneous seizures. However, it is not clear that kindling has a human correlate, so models in which an initial insult (status epilepticus, hyperthermia, hypoxia, trauma) is followed by the development of lowered seizure threshold and, in some instances, spontaneous seizures have been used. These models seem to support the 'second hit' hypothesis, in which there is an initial insult resulting in lowered seizure threshold, and then a later insult, the 'second hit', that results in the expression of epilepsy. These models also support the concept of a latent period during which there could be targeted therapies to prevent the epileptogenic process. Although the occurrence of neuronal damage is one such target, neuronal damage is not necessary for epileptogenesis, and other mechanisms are at play. At the present time, it is not known whether targeted therapies may also affect compensatory processes, such as brain repair. Clearly, this would be a potential risk of such strategies. Epidemiological evidence and trials indicate that our present antiepileptic drugs are not effective in preventing epileptogenesis; antiepileptic drugs were, however, not designed for this purpose. Data from animal experiments suggest that treatment of non-convulsive status epilepticus following specific insults may prevent epileptogenesis. The relevance of this for the human condition remains uncertain, but non-convulsive status epilepticus is probably an under-recognized and probably under-treated condition. Perhaps one of the most salutary findings has been the observation of decreased childhood epilepsy with improved neonatal care. This highlights the importance of medical care at the time of an insult, and of prevention of the insults. This review discusses the data that support the concepts underlying epileptogenesis and the model systems that are presumed to reflect the human condition. Particular attention is paid to the potential for interrupting the processes underlying epileptogenesis.

Adult Neurogenesis in Epileptogenesis: an Update for Preclinical Finding and Potential Clinical Translation

New Insights into the Role of Aberrant Hippocampal Neurogenesis in Epilepsy

The Role of Adult Hippocampal Neurogenesis in Epilepsy and Comorbidities

Temporal Lobe Epilepsy and Adult Hippocampal Neurogenesis

Neuroinflammation in Epileptogenesis: from Pathophysiology to Therapeutic Strategies

Neurogenesis and Its Links to Brain Development, Developmental Therapeutics, and the Pathogenesis of Neurodegenerative Disorders Including HIV-1-associated Dementia

Disease modification in partial epilepsy

The Neurovascular Unit Dysfunction in the Molecular Mechanisms of Epileptogenesis and Targeted Therapy

Research progress in molecular mechanisms of epileptogenesis

A stolen future: aberrant hippocampal neurogenesis produces glial cells in epilepsy

[New developments in epileptogenesis and therapeutic perspectives]

Neuroinflammation and Neurogenesis in Alzheimer’s Disease and Potential Therapeutic Approaches

Biomolecular mechanisms of epileptic seizures and epilepsy: a review

A critical period of neuronal activity results in aberrant neurogenesis rewiring hippocampal circuitry in a mouse model of epilepsy

Adult neurogenesis and neurodegenerative diseases: A systems biology perspective

Adult-born neurons in critical period maintain hippocampal seizures via local aberrant excitatory circuits

Integrating adult neurogenesis and human brain organoid models to advance epilepsy and associated behavioral research

Metabotropic glutamate receptors (mGluRs) in epileptogenesis: an update on abnormal mGluRs signaling and its therapeutic implications

The Role of Wnt/β-Catenin Signaling Pathway in Disrupted Hippocampal Neurogenesis of Temporal Lobe Epilepsy: A Potential Therapeutic Target?

An insight into crosstalk among multiple signaling pathways contributing to epileptogenesis

Immune mechanisms in epileptogenesis.